男受被做哭激烈娇喘gv视频,成人片免费网站,今天高清视频免费播放作文,欧美大片ppt免费

    《2006CCO診斷性成像評估轉移性和復發性卵巢癌》內容簡介：

    This recommendations report was developed to provide some initial guidance to Ontariohealth care providers and planners on the use of cross-sectional diagnostic imaging technologyfor patients with metastatic or recurrent ovarian cancer. While diagnostic imaging has animportant role in helping clinicians differentiate between benign and malignant disease, anddiagnostic imaging using ultrasound （US） remains the modality of choice for this initial staging,the definitive staging of ovarian cancer occurs surgically.

    《2006CCO診斷性成像評估轉移性和復發性卵巢癌》內容預覽：

    In 2003, CCO established a small working panel, the Diagnostic Imaging Panel,consisting of medical, radiation and surgical oncologists, diagnostic radiologists andmethodologists, to review guidelines published during the last five years on the use of cross-sectional imaging in oncology. After examining documents from nineteen guideline developers,the panel concluded that the available guidelines did not focus on the particular issues ofinterest here. Therefore, the panel decided to review the primary research and developrecommendations for Ontario on the use of CT, MRI and ultrasound （US） for any additionalstaging, assessment of tumour response during active treatment, and follow-up for patients withsix types of cancer: lymphoma, breast cancer, colorectal cancer, prostate cancer, lung cancerand ovarian cancer.

    A systematic review of the literature identified few randomized studies to provideguidance on the use of cross-sectional imaging in the management of patients with cancer;therefore, it was decided to also include cohort studies and case series reports in the evidencereview and incorporate expert opinion in the development of the recommendations. The initialselection and summary of relevant evidence was completed by methodologists at the Programin Evidence-Based Care in consultation with the clinical experts from the Diagnostic ImagingPanel （see Section IV）.

    點擊下載***：《2006CCO診斷性成像評估轉移性和復發性卵巢癌》